Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALTHX.PA
- Price
- 0.40
- Stock movement down
- -0.03 (-7.88%)
- Company name
- Theranexus SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 3.10M
- Ent value
- 6.95M
- Price/Sales
- 1.22
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -12.17%
- 1 year return
- -65.25%
- 3 year return
- -43.70%
- 5 year return
- -44.32%
- 10 year return
- -
Last updated: 2025-04-08
DIVIDENDS
ALTHX.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.22 |
| Price to Book | - |
| EV to Sales | 2.74 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 7.81M |
| EPS (TTM) | -0.87 |
| FCF per share (TTM) | -1.36 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.53M |
| Gross profit (TTM) | -1.55M |
| Operating income (TTM) | -8.11M |
| Net income (TTM) | -6.73M |
| EPS (TTM) | -0.87 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -61.32% |
| Operating margin (TTM) | -320.42% |
| Profit margin (TTM) | -265.66% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 415.76K |
| Net receivables | 1.20M |
| Total current assets | 3.05M |
| Goodwill | 0.00 |
| Intangible assets | 1.03M |
| Property, plant and equipment | 0.00 |
| Total assets | 4.26M |
| Accounts payable | 1.11M |
| Short/Current long term debt | 2.94M |
| Total current liabilities | 2.52M |
| Total liabilities | 4.27M |
| Shareholder's equity | -3.45K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -10.59M |
| Capital expenditures (TTM) | 35.31K |
| Free cash flow (TTM) | -10.55M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -157.78% |
| Return on Invested Capital | -569.32% |
| Cash Return on Invested Capital | -892.76% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.43 |
| Daily high | 0.44 |
| Daily low | 0.26 |
| Daily Volume | 72K |
| All-time high | 22.70 |
| 1y analyst estimate | 6.20 |
| Beta | 2.35 |
| EPS (TTM) | -0.87 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALTHX.PA | S&P500 | |
| Current price drop from All-time high | -98.26% | -17.71% |
| Highest price drop | -98.26% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -67.46% | -11.07% |
| Avg time to new high | 87 days | 12 days |
| Max time to new high | 1084 days | 1805 days |
COMPANY DETAILS
Marketcap
3.10M
Marketcap category
Small-cap
Description
Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.
Employees
12
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found